Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2900
https://www.valueinhealthjournal.com/article/S1098-3015(17)33234-5/fulltext
Title :
Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33234-5&doi=10.1016/j.jval.2017.08.2900
First page :
A928
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2669